Share on

Middle East and Africa Vascular Guidewires Market Research Report – Segmented By Product, Coating Type, End-User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Size, Share, Trends and Growth Forecast (2023 to 2028)

Published: March, 2023
ID: 6683
Pages: 145
Formats: report pdf report excel report power bi report ppt

MEA Vascular Guidewires Market Size (2023 to 2028)

The size of the Vascular Guidewires Market in the Middle East and Africa is estimated to rise at a steady CAGR during the forecast period.

The market for MEA vascular guidewires is expected to rise at a faster rate because of technological advancements and an increase in the geriatric population, which is more prone to chronic illnesses including cardiovascular disease, urological disease, and neurovascular disorders.

The market for guidewires is predicted to grow as the frequency of cardiovascular disorders increases with age, and surgical procedures are likely to boost demand. In addition, other factors such as the growing adoption of minimally invasive surgical procedures, the rising number of emerging economies with lifestyle disorders, various reimbursement schemes in developed countries, and technological advancements are also expected to boost the MEA vascular guidewires market.

There are significant profit opportunities in the Middle East and Africa due to the growing demand for vascular guidewires. There will be a nearly 2-fold increase in the percentage of over-60s between 2015 and 2050, from 12 percent to 22 percent. In addition, 109 nations and over 90% of the world's population are affected by neurological disorders, according to a study by the World Federation of Neurology (WFN) and the World Health Organization (WHO).

However, the problems associated with vascular guidewires and the availability of effective traditional treatment options are expected to limit the growth of the MEA vascular guidewires market. Furthermore, high surgical guidewire prices and escalating excise tax cuts are expected to hamper the guidewire market's growth throughout the forecast period.

This research report on the Middle East and Africa vascular guidewires market has been segmented and sub-segmented into the following categories.

By Product

  • Coronary Guidewires
  • Peripheral Guidewires

By Coating Type

  • Coated
    • Hydrophobic Coatings
    • Non-Hydrophobic Coatings
  • Non-Coated

By End-User

  • Hospitals
  • Ambulatory Surgical Centers

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Middle East and Africa accounted for a modest share of the global market, but this percentage is estimated to accelerate during the forecast period. Growth is expected to be supported by an increasing number of healthcare facilities, public awareness of cardiovascular treatment methods, and government initiatives to develop medical infrastructure. Two factors contributing to the region's rapid growth are the rising incidence of neurological diseases and the growing use of minimally invasive surgical procedures. Neurosurgery and skull-based surgery are undergoing a paradigm shift. As a result of endoscopic procedures, doctors can see and remove lesions previously treated with major, open procedures, driving up demand for guidewires in the region. Furthermore, prominent Middle Eastern companies are expected to develop new surgical instruments in the years ahead.

In the MEA region, the Vascular Guidewires market is dominated by the Middle East. This is due to several factors, including an increase in the frequency of target diseases, constant product introductions by key manufacturers, and favorable medical reimbursements for guidewires in MEA nations.

Africa, after the Middle East, has the largest share in the MEA region. With the expanding number of individuals suffering from heart disease, new technologies are being developed to give doctors and patients the most excellent possible surgical experience. Since the last decade, guidewire technology has grown dramatically as cardiologists have expanded their practice to deal with far more complex problems, primarily cardiac ailments.

KEY MARKET PLAYERS:

A few of the companies dominating the MEA vascular guidewires market are Abbott Laboratories, Terumo Corporation, B. Braun Melsungen AG, Medtronic plc, Biotronik SE & Co. KG, Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., C. R. Bard, Inc., and The Spectranetics Corporation.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample